C:VIT

Automated Vitrification

C:VIT provides for a faster, more reliable, and more efficient method for vitrification.

It standardizes the introduction of cryoprotectants and the loading of a novel CryoDevice to reduce variability and contamination risks, while minimizing workload burden. This innovative CryoDevice (patent pending) helps achieve cooling rates 50 times faster than current methods, minimizing ice crystal formation, and potentially allowing for lower cryoprotectant concentrations. C:VIT also incorporates  programmatic walk-away time ideal for optimized clinician supervision. 

Introduction

C:VIT provides a faster, more reliable, and more efficient method for vitrification. By standardizing the introduction of cryoprotectants and the loading of the CryoDevice this innovative CryoDevice (patent pending) helps achieve cooling rates 50 times faster than current methods, minimizing ice crystal formation, and allows for lower cryoprotectant concentrations. C:VIT addresses challenges including variability and contamination risks, and workload burden. It incorporates programmatic walk-away time ideal for optimized clinician supervision. 

Key Features

  • Faster Freeze and Thaw Times

  • Consistent Cell Preparation 

  • Standardized Protocols

Benefits

Consistency

The robotic precision of the system ensures movement of cells through all stages of the vitrification process including: cell preparation, dehydration, rapid cooling, storage transfer, and thawing.

Sterility

By operating in a controlled, microbial free environment, the C:VIT workstation minimizes the risk of contamination.

Relative Independence

Following the manual loading of cryoprotectants and CryoDevice, the C:VIT workstation operates in a fully autonomous mode, with vitrified samples packed into vials and robotically loaded in a transportation cooler and robotically loaded in a transportation cooler.

Efficiency

Automation reduces the time and effort required for vitrification, allowing embryologists to focus on other tasks within the IVF process.

Conclusion

C:VIT allows for standardization of vitrification, offers more consistent success rates, creates time and cost savings, and improves patient outcomes. C:VIT’s proprietary carrier device (referred to as CryoDevice) holds samples directly before LN₂ immersion and is paramount for the development of a successful automated routine. The CryoDevice is simple to use, non-toxic, resistant to LN₂, and is capable of holding the minute volumes used in vitrification (less than 1 µL). C:VIT achieves cooling rates 50 times faster than current methods.